J., and Forte, C
Metabolic liver disease Real-world registry data from Sweden, Denmark, and Norway (20072020) showed a reduced incidence of acute liver events in individuals with type 2 diabetes initiating GLP-1RA therapy compared to dipeptidyl peptidase 4 (DPP-4) inhibitors
Proponents suggest that certain probiotic strains may increase endogenous GLP-1 secretion by improving gut barrier function, reducing inflammation, or producing short-chain fatty acids that stimulate L-cells
Hence, we have opted for a bicycle ergometer test lasting 13 min for our study
Weekly injections, ongoing monitoring, and the need to manage side effects can become burdensome over time
That inflammatory response may lead to symptoms that feel flu-like or detox-like, such as fatigue, headache, chills, brain fog, digestive upset, muscle aches, skin changes, or mood shifts